Serum HMGB1 is a biomarker for acute myocardial infarction with or without heart failure
Serum HMGB1 is a biomarker for acute myocardial infarction with or without heart failure
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
This study measured serum high mobility group box 1 (HMGB1) levels in patients with acute myocardial infarction (AMI) and/or heart failure (HF) and evaluated their relationship with peripheral inflammatory biomarkers and cardiac biomarkers, which have not been reported before. Of the patients, 55 had AMI without HF (AMI
−HF
), 42 had AMI with...
Alternative Titles
Full title
Serum HMGB1 is a biomarker for acute myocardial infarction with or without heart failure
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7bf63a53c5fa45ff994b12f78326d2f2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7bf63a53c5fa45ff994b12f78326d2f2
Other Identifiers
ISSN
1752-8054
E-ISSN
1752-8062
DOI
10.1111/cts.13630
